The Philippines government also fined Sanofi a symbolic $2,000 (£1,476.30) Health Secretary Francisco Duque told Reuters.

"Sanofi Pasteur confirms that in accordance with international and local laws, regulations and company standards, post-approval commitments for Dengvaxia, as described in the pharmacovigilance plan submitted to the Philippines FDA and other national regulatory authorities, have been – and will continue to be – fulfilled," a Sanofi spokesman said.

(Reporting by Matthias Blamont; Editing by Geert De Clercq)